Page last updated: 2024-09-04
bisaramil and tesaglitazar
bisaramil has been researched along with tesaglitazar in 1 studies
Compound Research Comparison
Studies (bisaramil) | Trials (bisaramil) | Recent Studies (post-2010) (bisaramil) | Studies (tesaglitazar) | Trials (tesaglitazar) | Recent Studies (post-2010) (tesaglitazar) |
---|---|---|---|---|---|
22 | 1 | 1 | 74 | 13 | 25 |
Protein Interaction Comparison
Protein | Taxonomy | bisaramil (IC50) | tesaglitazar (IC50) |
---|---|---|---|
Chain A, PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA | Homo sapiens (human) | 0.6 | |
Chain A, PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA | Homo sapiens (human) | 0.6 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.35 | |
Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 3.8 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Other Studies
1 other study(ies) available for bisaramil and tesaglitazar
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |